IBEX vs Innodata
IBEX and INOD side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IBEX and INOD compare
Innodata is the larger company, worth 1.6 times as much as IBEX ($1.2B against $756M).
On earnings, IBEX is cheaper: it trades at 17.2× trailing earnings, against 25.9× for Innodata.
Innodata grew revenue faster over the last twelve months (46.9% versus 15.2% for IBEX).
Innodata keeps more of each dollar of sales as profit, with a net margin of 13.8% compared with 7.3% at IBEX.
Innodata scores higher on the StockData Score (18 against 17 for IBEX), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IBEX | INOD |
|---|---|---|
| Size and price | ||
| Market cap | $756M | $1.2B |
| Share price | $56.92 | $35.46 |
| Change, 1 year | 54.7% | −42.8% |
| Change, 5 years | 221% | 390% |
| Beta (5Y) | 0.73 | 2.76 |
| Employees | 35K | 10K |
| StockData Score | ||
| Total score | 17 | 18 (better) |
| Valuation score | 2 | 5 (better) |
| Growth score | 3 | 3 |
| Performance score | 6 (better) | 4 |
| Health score | 6 | 6 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 17.2× (better) | 25.9× |
| P/S | 1.1× (better) | 3.5× |
| P/B | 4.2× (better) | 6.9× |
| EV/EBITDA | 9.0× (better) | 16.2× |
| P/FCF | 23.4× | 14.7× (better) |
| PEG | 0.74 | – |
| FCF yield | 4.3% | 6.8% (better) |
| Fair value | $60.76 | $59.56 |
| Margin of safety | 6.3% | 40.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 15.2% | 46.9% (better) |
| Revenue growth, 5Y average | 7.8% | 34.0% (better) |
| Net income growth (TTM) | 18.6% | 44.1% (better) |
| EPS growth (TTM) | 18.7% | 34.3% (better) |
| EPS growth, 5Y average | 34.5% | 115% (better) |
| Profitability | ||
| Gross margin | 29.4% | – |
| Operating margin | 8.9% | – |
| Net margin | 7.3% | 13.8% (better) |
| FCF margin | 4.8% | 23.7% (better) |
| Return on equity | 30.2% | 35.4% (better) |
| Return on invested capital | 36.8% | – |
| Financial health | ||
| Debt / equity | 0.01 (better) | 0.00 |
| Net debt / EBITDA | −0.44 | – |
| Interest coverage | 64.9× | – |
| Current ratio | 2.03 | 2.84 (better) |
| Altman Z-score | 6.33 | 10.30 (better) |
| Piotroski F-score | 8 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.00% |
| Years of dividend growth | – | 0 |
| Buyback yield | 2.1% | – |
| Shareholder yield | 2.1% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 78.6% | 57.1% |
| Held by insiders | 23.8% | 14.1% |
| Insider net buying, 12 months | −$7.5M (better) | −$161M |
| Short interest, % of float | 1.9% | 17.1% |
Go deeper
- IBEX stock overview
- IBEX income statement
- IBEX valuation and score
- INOD stock overview
- INOD income statement
- INOD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.